glp 1 and cognitive function Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease Parkinson's disease | Journal of Biomedical Science GLP-1 and the Degenerating Brain:

In that study, semaglutide resulted in an 18% reduction in the HF composite outcome (HR 0.82

Viral hijack of hACE2 in the BBB axis could impair autonomic nervous system (ANS) and dysregulate blood pressure and respiration 76

Her research suggests that treatment continuity may be lower than expected and may reflect differences in efficacy, tolerability, or patient preference

These include leptin sensitizers, Y2R agonists (Eli Lilly, Novo Nordisk), amylin/calcitonin dual agonists (Nordic Biosciences, Amylin Pharmaceuticals), and ghrelin-targeting agents (Noxxon, Cytos) Novel mechanisms : There are several companies taking differentiated (non-incretin) approaches to obesity